Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Invested Capital: 2020-2025

Historic Invested Capital for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $31.5 million.

  • Journey Medical's Invested Capital rose 2.64% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 million, marking a year-over-year increase of 2.64%. This contributed to the annual value of $44.9 million for FY2024, which is 28.53% up from last year.
  • Per Journey Medical's latest filing, its Invested Capital stood at $31.5 million for Q3 2025, which was up 37.08% from $23.0 million recorded in Q2 2025.
  • Journey Medical's Invested Capital's 5-year high stood at $56.2 million during Q1 2022, with a 5-year trough of -$11.7 million in Q3 2021.
  • Over the past 3 years, Journey Medical's median Invested Capital value was $30.3 million (recorded in 2023), while the average stood at $27.7 million.
  • In the last 5 years, Journey Medical's Invested Capital slumped by 271.61% in 2021 and then skyrocketed by 492.72% in 2022.
  • Over the past 5 years, Journey Medical's Invested Capital (Quarterly) stood at $42.9 million in 2021, then grew by 4.41% to $44.7 million in 2022, then decreased by 21.85% to $35.0 million in 2023, then climbed by 28.53% to $44.9 million in 2024, then rose by 2.64% to $31.5 million in 2025.
  • Its Invested Capital was $31.5 million in Q3 2025, compared to $23.0 million in Q2 2025 and $23.4 million in Q1 2025.